Trace Neuroscience has launched in the U.S. with over $100 million in financing and a goal to develop its UNC13A-targeted treatment for ALS.

Columnist Kristin Neva sometimes get overwhelmed by her increasing caregiver responsibilities, but it helps her to know she's not alone.

This November, the nonprofit I AM ALS is launching a peer support program as part of its new campaign focused on supporting ...

Leal Therapeutics raised $45 million for drug development, including advancing a promising therapy into clinical trials for ...

The funding will help support the Ontario Provincial ALS Program to meet the needs of the roughly 1,300 people in Ontario ...

Altered activity of ancient viral genes were linked to neurodegenerative diseases including ALS in a recent analysis.

Drinking straws are one of the tools in columnist Dagmar Munn's arsenal to combat dysphagia while living with ALS.

Columnist Kristin Neva and her husband with ALS are sometimes asked about the way they went about building their accessible home.

The National Institute of Aging awarded a $7.3 million research grant for the study of NU-9 as a treatment for ...

Kadimastem, the developer of the experimental amyotrophic lateral sclerosis (ALS) therapy AstroRx, is merging with NLS ...

Mitochondrial genome mutations may be linked to ALS, per a study, opening the door for new ways to diagnosing and treating ...

Auttx has received a grant from the ALS Network to advance research on treatments for ALS that could restore normal RNA ...